The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.

Nontawong, Nuttakant; Siripongboonsitti, Taweegrit; Tawinprai, Kriangkrai; Boonpratoom, Mana; Krailassiri, Nawin; Boonkhum, Chayaporn; Soonklang, Kamonwan; Poovorawan, Yong; Mahanonda, Nithi

Nontawong, Nuttakant; Siripongboonsitti, Taweegrit; Tawinprai, Kriangkrai; Boonpratoom, Mana; Krailassiri, Nawin; Boonkhum, Chayaporn; Soonklang, Kamonwan; Poovorawan, Yong; Mahanonda, Nithi.

Afiliación

Nontawong N; Department of Medicine, Prachathiput Hospital, Pathum Thani, Thailand.
Siripongboonsitti T; Division of Infectious Diseases, Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand. Taweegrit.sir@cra.ac.th.
Tawinprai K; Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand. Taweegrit.sir@cra.ac.th.
Boonpratoom M; Division of Infectious Diseases, Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
Krailassiri N; Naungsau Hospital, Pathum Thani, Thailand.
Boonkhum C; Naungsau Hospital, Pathum Thani, Thailand.
Soonklang K; Department of Medicine, Prachathiput Hospital, Pathum Thani, Thailand.
Poovorawan Y; Center of Learning and Research in Celebration of HRH Princess Chulabhorn 60th Birthday Anniversary, Chulabhorn Royal Academy, Bangkok, Thailand.
Mahanonda N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Ann Clin Microbiol Antimicrob ; 21(1): 51, 2022 Nov 19.

Article en En | MEDLINE | ID: mdl-36403020

Asunto(s)

Anticuerpos Neutralizantes; COVID-19; Humanos; COVID-19/terapia; Estudios de Casos y Controles; Inmunización Pasiva; Tratamiento Farmacológico de COVID-19; Sueroterapia para COVID-19

Palabras clave

COVID-19; Convalescent plasma; Mortality; Severe COVID-19

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Ann Clin Microbiol Antimicrob Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Tailandia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google